Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Clonally expanded CD8+ T cells cause alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Younger people and those with existing acne are more likely to get folliculitis after hair restoration surgery, but it doesn't affect the overall good hair growth result.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Thymosin β4 helps increase hair growth in Cashmere goats.

Eyebrow hair transplants can regrow after high-dose radiation therapy.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Ciclosporin A effectively treated a cat's severe skin condition.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Thymosin β4 may boost hair growth by aiding stem cell movement and blood vessel formation.

YAP1 is important for skin regeneration and may affect skin disorder treatments.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Hair transplantation between identical twins can successfully treat severe, nonprogressive hair loss due to follicular aplasia.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.